CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 114 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 11 | -100.0% | 0.00% | -100.0% |
| Q3 2017 | $3,619,000 | +442.6% | 245,337 | +413.6% | 0.00% | +300.0% |
| Q2 2017 | $667,000 | +16.2% | 47,772 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $574,000 | -16.7% | 51,109 | +1.4% | 0.00% | 0.0% |
| Q1 2016 | $689,000 | +40.3% | 50,401 | +95.0% | 0.00% | 0.0% |
| Q4 2015 | $491,000 | +1536.7% | 25,853 | +1192.6% | 0.00% | – |
| Q2 2015 | $30,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2015 | $30,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |